Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating
Patients With Hematologic Cancer
Basic Study Information
Purpose:
RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. Drugs
used in
chemotherapy use different ways to stop cancer cells from dividing so they stop growing
or
die. Combining chemotherapy with donor peripheral stem cell transplantation may allow
the
doctor to give higher doses of chemotherapy drugs and kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining total-body irradiation
with
fludarabine and donor peripheral stem cell transplantation in treating patients who
have
hematologic cancer.
Location: James P. Wilmot Cancer Center at University of Rochester Medical Center
Study Contact Information
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search